Prostate Carcinoma: Clinical Trials

7 trials for Prostate Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 3 completed, 1 withdrawn. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Active not recruiting 3, Completed 3, Withdrawn 1

Follow Prostate Carcinoma: new trials by email Literature Review of Prostate Carcinoma trials Research Report on Prostate Carcinoma

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center302025-08-012026-10-20
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer
Phase 1Active not recruitingAtavistik Bio, Inc1342025-07-292026-08-07
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
Bendamustine, Biopsy, Biospecimen Collection - Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma
Phase 1WithdrawnFred Hutchinson Cancer Center2025-04-152025-04-01
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Prostate Gland, Prostate Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center302020-09-092026-08-20
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
XmAb®22841, Pembrolizumab (Keytruda®) - Melanoma, Cervical Carcinoma
Phase 1CompletedXencor, Inc.782019-05-292023-03-30
Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants
Selenium, Placebo, Laboratory Biomarker Analysis - No Evidence of Disease, Prostate Carcinoma
Phase 1CompletedNational Cancer Institute (NCI)662011-11-012014-11-26
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
Laboratory Biomarker Analysis, Pharmacological Study, Veliparib - Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier
Phase 1CompletedNational Cancer Institute (NCI)982009-04-202018-06-29

Narrower conditions

Prostatic Neoplasms (7)  ·  Breast Neoplasms (3)  ·  Ovarian Neoplasms (3)  ·  Pancreatic Neoplasms (3)  ·  Triple Negative Breast Neoplasms (3)  ·  Uterine Cervical Neoplasms (3)  ·  Anus Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Transitional Cell (2)  ·  Cholangiocarcinoma (2)  ·  Colorectal Neoplasms (2)  ·  Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Uterine Neoplasms (2)

Broader conditions

Genital Diseases (7)  ·  Genital Diseases, Male (7)  ·  Genital Neoplasms, Male (7)  ·  Male Urogenital Diseases (7)  ·  Prostatic Diseases (7)  ·  Urogenital Diseases (7)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Urogenital Neoplasms (6)  ·  Adnexal Diseases (4)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases, Female (4)

Interventions

FAPI-46 (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Bendamustine Hydrochloride (1)  ·  Biopsy (1)  ·  Bridge Therapy (1)  ·  Cyclophosphamide (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Fulvestrant (1)  ·  Leukapheresis (1)  ·  Phantoms, Imaging (1)  ·  Selenium (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  fludarabine (1)  ·  pembrolizumab (1)

Sponsors

Jonsson Comprehensive Cancer Center (2)  ·  National Cancer Institute (NCI) (2)  ·  Atavistik Bio, Inc (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Xencor, Inc. (1)

Countries

United States (7)  ·  France (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Jeremie Calais (2)  ·  Benjamin Thompson, MD, PhD (1)  ·  Michael Schweizer (1)  ·  Raymond Bergan (1)  ·  Shannon Puhalla (1)

Results publications

PMID 33433743

NIH funding

N01CN35157 (1), P30CA047904 (1), P30CA060553 (1), U01CA062505 (1), U01CA099168 (1), U01CA132194 (1), UM1CA186690 (1), UM1CA186716 (1), UM1CA186717 (1)